- Trials with a EudraCT protocol (44,380)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
44,380 result(s) found.
Displaying page 2,177 of 2,219.
| EudraCT Number: 2016-000888-16 | Sponsor Protocol Number: 16-001 | Start Date*: 2018-05-17 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Bronchoscopic indocyanine green fluorescence imaging for the evaluation of anastomotic healing after lung transplantation | ||
| Medical condition: Anastomotic healing after lung transplantation | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-004929-33 | Sponsor Protocol Number: SiccaIkervis | Start Date*: 2018-12-05 |
| Sponsor Name:KH Hietzing, Department of Ophthalmology | ||
| Full Title: Effect of Ciclosporin eyedrops on ocular symptoms and optical image quality in patients with primary or secondary Sjögren syndrome | ||
| Medical condition: primary or secondary Sjögren Syndrome | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-004494-27 | Sponsor Protocol Number: 5020DERM-2018 | Start Date*: Information not available in EudraCT | ||||||||||||||||
| Sponsor Name:Landeskrankenhaus Salzburg | ||||||||||||||||||
| Full Title: pilotstudy- efficacy of infectoscab 5% creme in patients with scabies | ||||||||||||||||||
| Medical condition: Scabies | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: AT (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2012-000142-35 | Sponsor Protocol Number: UC-0160/1105 | Start Date*: 2014-05-19 | |||||||||||
| Sponsor Name:UNICANCER | |||||||||||||
| Full Title: A prospective randomised phase III study of androgen deprivation therapy with or without local radiotherapy with or without abiraterone acetate and prednisone in patient with metastatic hormone-na... | |||||||||||||
| Medical condition: metastatic hormone-naïve prostate cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: FR (Completed) ES (Ongoing) IE (Completed) BE (Completed) IT (Completed) DE (Completed) RO (Completed) GR (Ongoing) PT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-000941-10 | Sponsor Protocol Number: CLI24-001 | Start Date*: 2020-07-02 |
| Sponsor Name:Menarini Ricerche S.p.A | ||
| Full Title: A Phase I/II Study of SEL24 in Patients with Acute Myeloid Leukemia | ||
| Medical condition: Acute Myeloid Leukemia | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: PL (Completed) ES (Completed) IT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2018-003675-35 | Sponsor Protocol Number: WV2018 | Start Date*: 2018-11-01 |
| Sponsor Name:Karolinska Institutet | ||
| Full Title: Efficacy of Very Early Medical Abortion – a randomized controlled non-inferiority trial | ||
| Medical condition: Unwanted pregnancy | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: SE (Completed) FI (Completed) AT (Completed) DK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-002828-85 | Sponsor Protocol Number: RG_15-114 | Start Date*: 2017-04-28 | |||||||||||||||||||||
| Sponsor Name:University of Birmingham | |||||||||||||||||||||||
| Full Title: Paediatric Hepatic International Tumour Trial | |||||||||||||||||||||||
| Medical condition: Hepatoblastoma and Hepatocellular Carcinoma. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) IE (Trial now transitioned) ES (Ongoing) NO (Trial now transitioned) DE (Ongoing) CZ (Trial now transitioned) BE (Trial now transitioned) FR (Trial now transitioned) NL (Trial now transitioned) PL (Trial now transitioned) AT (Trial now transitioned) SE (Completed) FI (Completed) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2015-002055-10 | Sponsor Protocol Number: PURE-01 | Start Date*: 2020-07-06 |
| Sponsor Name:Fondazione IRCCS Istituto Nazionale dei Tumori | ||
| Full Title: PURE-01 – An open label, single-arm, phase 2 study of neoadjuvant pembrolizumab (MK-3475) before cystectomy for patients with muscle-invasive urothelial bladder cancer. | ||
| Medical condition: muscle-invasive urothelial bladder cancer | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) IT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-004319-37 | Sponsor Protocol Number: 001.4 | Start Date*: 2019-06-19 | |||||||||||
| Sponsor Name:Medical University of Vienna, Department of Surgery | |||||||||||||
| Full Title: A prospective, randomised, single-blind explorative study to investigate the efficacy and safety of fat graft enrichment with autologous platelet lysate in female breast augmentation | |||||||||||||
| Medical condition: Fat grafting e.g. to the breast to restore small tissue defects is a very common and safe surgical procedure. Its main success among other is depended on the survival rate of the transferred fat ti... | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2019-001340-22 | Sponsor Protocol Number: CathLockTrialHD | Start Date*: 2020-02-24 |
| Sponsor Name:Universtitätsklinikum St.Pölten | ||
| Full Title: A prospective, randomized, multicenter trial to compare a Taurolock™ based lock solution to a Citrate and Citrate/Urokinase based lock solution in tunneled hemodialysis catheters for the prevention... | ||
| Medical condition: Patients requiring hemodialysis with a CVC due to renal failure of any cause. Aim of this study is to investigate different CVC lock Solutions. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-005116-64 | Sponsor Protocol Number: 16092021 | Start Date*: 2021-12-13 | |||||||||||
| Sponsor Name:Aarhus University Hospital, Department of Anesthesiology | |||||||||||||
| Full Title: Low-dose ketamine as an adjunct to morphine for acute pain in the ED: a randomized, double-blinded, superiority trial | |||||||||||||
| Medical condition: Acute pain in the Emergency Department | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-005768-74 | Sponsor Protocol Number: ImmunoSep | Start Date*: 2021-02-18 | |||||||||||
| Sponsor Name:Hellenic Institute for the Study of Sepsis | |||||||||||||
| Full Title: PERSONALIZED IMMUNOTHERAPY IN SEPSIS: A MULTICENTRE AND MULTINATIONAL, DOUBLE-BLIND, DOUBLE-DUMMY RANDOMIZED CLINICAL TRIAL (THE IMMUNOSEP TRIAL) | |||||||||||||
| Medical condition: Sepsis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GR (Completed) NL (Completed) DE (Completed) IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2020-000201-84 | Sponsor Protocol Number: AT2020_01 | Start Date*: 2020-04-07 |
| Sponsor Name:Das Kinderwunsch Institut Schenk GmbH | ||
| Full Title: Oral and intravenous iron substitution for the treatment of iron deficiency symptoms in the context of fertility treatment - an exploratory pilot study | ||
| Medical condition: infertility | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-000220-19 | Sponsor Protocol Number: 2.2 | Start Date*: 2020-09-24 |
| Sponsor Name:Verein zur Förderung von Wissenschaft und Forschung an der 1. Med. Abteilung der Krankenanstalt Rudolfstiftung | ||
| Full Title: Comparing effects of weight loss by Liraglutide 3.0 mg with conventional liver fasting in non-alcoholic fatty liver disease before bariatric surgery | ||
| Medical condition: Obesity and NAFLD can increase the risk and complexity of bariatric surgery up to 20%. Reducing the weight and liver size before bariatric surgery improves the operation area and reduces complicati... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-004489-16 | Sponsor Protocol Number: V3_KET_NEG_SYMPT_SCZ | Start Date*: 2021-11-03 |
| Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Psychiatrie und Psychotherapie | ||
| Full Title: Ketamine for the treatment of depressive and negative symptoms in patients with schizophrenia: a randomized controlled cross-over pilot study. | ||
| Medical condition: Negative and depressive symptoms of schizophrenia according to DSM-5 | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-003092-18 | Sponsor Protocol Number: TIKTAC | Start Date*: 2021-05-12 |
| Sponsor Name:Medical University Innsbruck | ||
| Full Title: Daratumumab in combination with Carfilzomib, Pomalidomide and Dexamethasone (DCPD) in patients with multiple myeloma induced acute renal failure - “Time Is Kidney in the Treatment of myelomA Cast n... | ||
| Medical condition: Multiple Myeloma: cohort 1: dialysis dependent patients; cohort 2: patients not dialysis dependent | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-005726-29 | Sponsor Protocol Number: CariCog | Start Date*: 2021-02-23 |
| Sponsor Name:Medical University Innsbruck | ||
| Full Title: An open label signal detection study to evaluate the effects of cariprazine on cognitive functioning in patients with schizophrenia in need of adjustment of oral antipsychotic treatment | ||
| Medical condition: Schizophrenia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: AT (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-004501-27 | Sponsor Protocol Number: 2183/2019 | Start Date*: 2021-01-28 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: Perioperative analgesia in children undergoing ophthalmic surgery | ||
| Medical condition: perioperative analgesia | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-002752-20 | Sponsor Protocol Number: LAN_POAF_01 | Start Date*: 2020-12-17 | |||||||||||
| Sponsor Name:Medical University of Vienna | |||||||||||||
| Full Title: A prospective, randomized, double- blind, placebo- controlled study to evaluate the efficacy of Landiolol hydrochloride for prevention of atrial fibrillation in patients undergoing cardiac surgery | |||||||||||||
| Medical condition: Perioperative atrial fibrillation (POAF) is the most common arryhthmia after cardiac surgery with incidences ranging from 20% to 40%, depending on various patient's risk factors and the type of sur... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-003255-15 | Sponsor Protocol Number: Benzylbenzoat-Ivermectin-5020 | Start Date*: 2020-12-17 |
| Sponsor Name:Landeskrankenhaus Salzburg | ||
| Full Title: Investigation to assess the efficacy of benzyl benzoate 10/25% emulsion versus oral ivermectin for scabies treatment | ||
| Medical condition: Scabies | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
